Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...

We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates.

Stanford Medicine researchers have built CRISPR-GPT, a large language model designed to automate the full arc of gene-editing ...

One year ago, a baby from Delaware County, Pennsylvania, became the first person in the world to receive a new revolutionary therapy at Children's Hospital of Philadelphia. "We didn't know that we ...

A Dallas-based biotech company called Colossal Biosciences says it has produced “de-extinct” dire wolf pups using gene-editing technology, but critics argue the animals are genetically modified gray ...

Crispr Therapeutics Ag (NASDAQ:CRSP) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Biotech company Crispr Therapeutics Ag (NASDAQ:CRSP) shares are up 16% over the past 12 months.

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Nearly 90,000 people in the US are diagnosed with Parkinson’s disease each year, with the primary risk factor being age. Parkinson’s disease is characterized by the progressive degeneration of ...

Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...